These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24042998)

  • 1. Therapeutic modalities in systemic lupus erythematosus.
    Tyagi NK; Lahita RG
    Saudi Med J; 2013 Sep; 34(9):887-95. PubMed ID: 24042998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
    Lee HJ; Sinha AA
    Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
    Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
    Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biological treatments for systemic lupus erythematosus: current and future modalities.
    Bezalel S; Asher I; Elbirt D; Sthoeger ZM
    Isr Med Assoc J; 2012 Aug; 14(8):508-14. PubMed ID: 22977972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New directions in the treatment of systemic lupus erythematosus.
    Kalunian K; Merrill JT
    Curr Med Res Opin; 2009 Jun; 25(6):1501-14. PubMed ID: 19435401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics in SLE: the current status.
    Rajadhyaksha AG; Mehra S; Nadkar MY
    J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
    Murdaca G; Colombo BM; Puppo F
    Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant B cell selection and activation in systemic lupus erythematosus.
    Kil LP; Hendriks RW
    Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell-directed therapies in systemic lupus erythematosus.
    Tieng AT; Peeva E
    Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic lupus erythematosus: from pathophysiology to treatment].
    Contin-Bordes C; Lazaro E; Pellegrin JL; Viallard JF; Moreau JF; Blanco P
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H9-13. PubMed ID: 19995652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for juvenile-onset systemic lupus erythematosus.
    Carreño L; López-Longo FJ; González CM; Monteagudo I
    Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory disease in systemic lupus erythematosus.
    Campar A; Farinha F; Vasconcelos C
    Autoimmun Rev; 2011 Sep; 10(11):685-92. PubMed ID: 21600313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel therapeutic possibilities in systemic lupus erythematosus].
    Bazsó A; Poór G; Gergely P; Kiss E
    Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic lupus erythematosus].
    Cikes N
    Reumatizam; 2000; 47(2):11-7. PubMed ID: 11552608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunometabolism in systemic lupus erythematosus.
    Morel L
    Nat Rev Rheumatol; 2017 May; 13(5):280-290. PubMed ID: 28360423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.